Sign In
Buy VTVT
$32.35
-0.330 (-1.01%)
At Close: Jul 31, 2026
Top 10 Biotech Penny Stocks to Watch in July 2021
04:24pm, Tuesday, 22'nd Jun 2021
Are these the best biotech penny stocks to watch next month? Here's 5 more for your list The post Top 10 Biotech Penny Stocks to Watch in July 2021 appeared first on Penny Stocks to Buy, Picks, News a
Why Moderna, Bio-Path Holdings And vTv Therapeutics Are Moving Today
10:45am, Tuesday, 22'nd Jun 2021
Moderna, Inc. (NASDAQ: MRNA), Bio-Path Holdings, Inc. (NASDAQ: BPTH) and vTv Therapeutics Inc. (NASDAQ: VTVT) are among the biggest biotech movers Tuesday. Moderna Gains On Additional EU Orders: Moder
vTv Therapeutics Shares Jump On Out-Licensing Agreement For Azeliragon In Cancer Settings
10:11am, Tuesday, 22'nd Jun 2021
Privately-held Cantex Pharmaceuticals Inc has entered into a licensing agreement with vTv Therapeutics Inc (NASDAQ: VTVT) to develop and commercialize vTv's azeliragon. Under the terms of the ag
HIGH POINT, N.C. and WESTON, Fla., June 22, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (“vTv”, Nasdaq:VTVT) and Cantex Pharmaceuticals, Inc. (“Cantex”) today announced that they have enter
What Are Penny Stocks? 4 to Buy [Or Sell] In 2021
02:58pm, Thursday, 10'th Jun 2021
Wondering what penny stocks are? Here's your answer and 4 to watch The post What Are Penny Stocks?
VTv Therapeutics (VTVT) Reports Q1 Loss, Tops Revenue Estimates
09:25pm, Wednesday, 05'th May 2021
vTv Therapeutics (VTVT) delivered earnings and revenue surprises of -50.00% and 23.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
vTv Therapeutics (VTVT) Gets Breakthrough Tag for Diabetes Drug
09:55am, Wednesday, 14'th Apr 2021
The FDA bestows a Breakthrough Therapy designation to vTv Therapeutics' (VTVT) TTP399 as an adjunctive therapy to insulin for treating type I diabetes. Shares rise.
VTVT Stock: The FDA News Sending vTv Therapeutics Soaring Today
02:49pm, Tuesday, 13'th Apr 2021
Today, VTVT stock is on the move as investors price in a key announcement from the FDA designating a leading drug a breakthrough therapy. The post VTVT Stock: The FDA News Sending vTv Therapeutics Soa
VTVT Stock: Over 15% Increase Pre-Market Explanation
07:44am, Tuesday, 13'th Apr 2021
The stock price of vTv Therapeutics Inc. (Nasdaq: VTVT) increased by over 10% pre-market. This is why it happened.
vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type 1 Diabetes
07:30am, Tuesday, 13'th Apr 2021
Designation offers potential for expedited development pathway and reinforces TTP399's potential to provide a substantial clinical benefit Designation offers potential for expedited development pathwa
HIGH POINT, N.C., April 12, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for
vTv Therapeutics Announces Issuance of U.S. Patent Covering Methods of Treatment Using TTP399
07:30am, Tuesday, 23'rd Mar 2021
Claims cover methods of reducing HbA1c and the incidence of hypoglycemia using TTP399 in patients with type 1 diabetes Claims cover methods of reducing HbA1c and the incidence of hypoglycemia using TT
HIGH POINT, N.C., March 18, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for
vTv Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
04:05pm, Monday, 08'th Mar 2021
HIGH POINT, N.C., March 08, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for
vTv Therapeutics Announces 2020 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
04:30pm, Wednesday, 24'th Feb 2021
Initiation of Mechanistic Study of TTP399 expected during Q1 2021
